MOVER · THU SEP 24 2026

Why GCTK rose 120.1% on Sep 24 2026: fee-for-service partnership

GCTK+120.1%on Thu Sep 24 2026

GlucoTrack, Inc. Common Stock was up 120.1% on the day at $4.47, ranked #3 on — its usual five-minute volume, when TapeRank recorded this spike at 04:01 ET during the pre-market session.

THE DAY ON THE LIST · 1 EVENT

  1. 04:01 ET
    MOVER · PRE-MARKET

    $4.47 · ▲ 120.1% ON THE DAY · — 5M RVOL · RANK #3

    STRETCHEDCONFIDENCE5/5

    GCTK is up 115.3% to $4.37, following news that a subsidiary secured its first external fee-for-service engagement to identify brain-tumor assets. The partnership has no disclosed financial terms or clinical milestone, while the magnitude of the move is extreme relative to the announcement, and the pending Series A preferred-stock conversion creates issuance risk.

    WHYA 115% move and $1.7M five-minute surge are far larger than an unquantified fee-for-service engagement with no disclosed economics or clinical result supports.
    ANALYZED 04:01 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNA
    THE ROW AND SESSION LEVELS AT 04:01 ET
    LAST4.47
    DAY▲ 120.1%
    5 MIN▲ 19.15%
    5M RVOL—
    5M $VOL$1.6M
    FLOAT*12.0M
    RANK#3
    SESSIONPRE-MARKET
    VWAP4.52
    HOD4.77
    LOD3.75
    OR HIGH—
    OR LOW—
    PREV CLOSE2.03
    PM HIGH4.77
    PM LOW3.75
    GAP▲ 120.10% (indicated)

    * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE

    — MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO

THE SESSION

  • 09:30 ETOpened at $2.43, +19.7% on the previous close of $2.03
  • 09:30 ETRegular-session low, $2.38
  • 09:39 ETRegular-session high, $3.25
  • 15:59 ETLast trade of the regular session, $2.58, +27.1% on the previous close of $2.03
  • Volume: 20.2M shares in regular hours, 30.7M before the open

GCTK opened at $2.43 after a $2.03 previous close and briefly slipped to $2.38 before reaching $3.25 by 09:39 ET. TapeRank recorded the stock at $4.47 in the premarket, with its read tying the move to news that a subsidiary secured its first external fee-for-service engagement to identify brain-tumor assets; the announcement disclosed no financial terms or clinical milestone, and TapeRank rated the move stretched. With no halts, the stock later retreated and finished the regular session at $2.58, still above the previous close.

WRITTEN THU OCT 15 2026 17:55 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE

FILINGS AND NEWS · 24H BEFORE THE MOVE

No SEC filings or wire news in the 24 hours before this was recorded. A move on news that never reached the wire shows nothing here, which is what UNEXPLAINED means.

On the tape right now

WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY

01
ECGSURGING 0:05
79.71
▼ 29.3%
▼ 1.41%
41.0×
FAD
$6.2M
51.1M*
STRETCHED
02
CAVASURGING 0:00
64.78
▲ 7.4%
▲ 1.30%
9.3×
ORBHODVWH
$11.6M
116.8M*
UNEXPLAINED
03
URGNSURGING 0:00
29.16
▼ 15.2%
▼ 1.29%
15.6×
FAD
$1.4M
48.9M*
JUSTIFIED
04
MPTISURGING 0:00
64.15
▼ 1.5%
▲ 0.96%
23.8×
VWH
$637K
4.3M*
UNEXPLAINED
05
LSPDSURGING 0:00
11.52
▲ 4.9%
▼ 1.24%
16.5×
ORB
$426K
133.3M*
UNEXPLAINED
06
CRCTSURGING 0:00
8.90
▲ 49.2%
▼ 0.72%
15.1×
GAPORBVWHEXT
$395K
54.7M*
STRETCHED
07
BROSSURGING 0:00
43.97
▲ 0.9%
▼ 0.91%
4.0×
FAD
$4.3M
137.9M*
UNEXPLAINED
08
LMRICOOLING 1:35
12.85
▲ 14.5%
▲ 1.06%
132×
ORBHODVWH
$1.7M
—
UNEXPLAINED
Open the full list